6Louzier V et al. Hun Gene Ther 2001;12 : 503 - 513.
7Ashutosh K, Phadke K,Jackson JF, et al. Use of nitric oxide inhalation in chronic obstructive pulmonary disease. Thoxax Feb 2000; 55:109 - 113.
8Nagya N .Am J Respir Crit Care Med 2001;163(4):887-891.
9Rubin LI, Badesch DB, Barst RJ, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002 ; 346 : 896-903.
10Olscheski H. Inhaled prostacyclin and ilopeost in severe pulmonary hy - pertension secondary to lung fibrosis. Am J Respin Crit Care Med 1999;160(2):600.
二级参考文献11
1曾广斌，中华内科杂志，1988年，27卷，548页
2Farrukh IS,et al. American Journal of Physiology . 1998
3Smimov SV,et al. American Journal of Physiology . 1994
4Peng W,et al. American Journal of Physiology . 1997
5Hood JS,et al. European Journal of Pharmacology . 1991
6Jesse RL,et al. Annals of the New York Academy of Sciences . 1995
7Scott AB. American Journal of Physiology . 1998
8Nelson MT,Quayle JM. American Journal of Physiology . 1995
9Albarwani S,et al. Journal of Physiology The . 1995
